Suppr超能文献

在重度哮喘背景下对生物制剂家庭给药的认知:一项国际定性研究。

Perceptions on Home-Administration of Biologics in the Context of Severe Asthma: An International Qualitative Study.

机构信息

General Practitioners Research Institute, Groningen, The Netherlands; Groningen Research Institute Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Department of Pediatric Pulmonology and Pediatric Allergology, University of Groningen, University Medical Center Groningen, Beatrix Children's Hospital, Groningen, The Netherlands.

General Practitioners Research Institute, Groningen, The Netherlands; Groningen Research Institute Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Observational and Pragmatic Research Institute, Singapore, Singapore; Department of Pulmonology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

出版信息

J Allergy Clin Immunol Pract. 2022 Sep;10(9):2312-2323.e2. doi: 10.1016/j.jaip.2022.04.015. Epub 2022 Apr 27.

Abstract

BACKGROUND

Biologics are an effective therapy for severe asthma. Home administration of biologics by patients is likely to facilitate their accessibility. Yet little is known about patients' and health care providers' (HCPs) perceptions regarding home administration of biologics.

OBJECTIVE

The aim of this study is to create more insight into the perceptions and experiences of patients and HCPs regarding home administration of biologics in the context of the treatment of severe asthma.

METHODS

A qualitative international study was performed in the Netherlands, United States, Australia, and United Kingdom. In each country, 2 focus groups were held with potential/recent and long-term users of biologics at home. Prior to the focus groups, patients were prompted with themes on online forums. For triangulation purposes, interviews were held with HCPs to discuss salient findings from forums and focus groups. Data were analyzed with qualitative content analysis.

RESULTS

In total, 75 patients participated in the forums, of which 40 participated in the focus groups. Furthermore, 12 HCPs were interviewed. The following overarching themes were identified: living with severe asthma; practical aspects of using biologics; the role of HCPs regarding biologics; social support from family, friends, and others; effectiveness of biologics and other treatments; side effects of biologics.

CONCLUSIONS

This study showed that, for those using biologics for severe asthma, the benefits of home administration of biologics usually outweigh inconvenience and side effects. Guided practice, accessible support contact, and monitoring including social support should be central in the transition from hospital to home administration of asthma biologics.

摘要

背景

生物制剂是治疗严重哮喘的有效疗法。患者在家中使用生物制剂可能会增加其便利性。然而,对于患者和医疗保健提供者(HCPs)对生物制剂的家庭管理的看法,我们知之甚少。

目的

本研究旨在深入了解患者和 HCPs 在治疗严重哮喘的背景下对生物制剂家庭管理的看法和经验。

方法

在荷兰、美国、澳大利亚和英国进行了一项定性的国际研究。在每个国家,都举行了 2 次潜在/近期和长期在家中使用生物制剂的患者焦点小组讨论。在焦点小组讨论之前,患者在在线论坛上提示了主题。为了进行三角分析,还与 HCPs 进行了访谈,以讨论论坛和焦点小组中发现的突出问题。使用定性内容分析对数据进行分析。

结果

共有 75 名患者参与了论坛,其中 40 名患者参加了焦点小组。此外,还采访了 12 名 HCPs。确定了以下总体主题:严重哮喘的生活;使用生物制剂的实际方面;HCPs 在生物制剂方面的作用;来自家人、朋友和其他人的社会支持;生物制剂和其他治疗的效果;生物制剂的副作用。

结论

本研究表明,对于那些因严重哮喘而使用生物制剂的患者来说,生物制剂家庭管理的好处通常超过不便和副作用。指导实践、可访问的支持联系以及包括社会支持在内的监测应该是从医院过渡到哮喘生物制剂家庭管理的核心。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验